Monday, May 24, 2010

Advanced Clinical: Asset Delivery

Upon signing your discovery to Advanced Clinical, you will find there are a lot of assets with your decision. Advanced Clinical is home of the Industry Leading Trial Performance Method, a method which carefully combines strategy, management, structures and execution strategies to advance discoveries.

Parts of our ILTP method include risk management, team integration, continuous learning, ramping/onboarding, project management with supply and demand management, recruiting and sourcing, and marketing.

Advanced Clinical takes a three-part overall approach to trials:
  • Collaborate: One team approach, we work together
  • Innovate: Work together to find the best technology and team members to find new ways of testing and advancing your discovery, apply the Industry Leading Trial Performance Method
  • Optimize: Enhance the trial after it has begun with continuous learning and training, make step-change improvements to better the trial

Does this sound like a great way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Friday, May 21, 2010

Big Pharma aims for reinvention

With some of his most profitable medicines going off patent, and the uncertainty of replacement drugs continuing to rise, US healthcare reform has been the least of Andrew Witty’s recent worries.

When the chief executive of GlaxoSmith­Kline presented his company’s most recent financial results last month, he gave a sense of how the UK’s biggest drugmaker – and the industry more generally – is responding to structural pressures: diversify to survive.

For his company, he says, this means a shift away from “white pills in western markets”, with the proportion of traditionally core patent-protected, chemically based drugs, which are sold mainly in North America and western Europe, falling to just more than a quarter of total sales.

For many years, large companies such as GSK have relied on a handful of typically high-priced, mass-market “blockbusters” that generate billions of dollars a year in sales. But as patents expire on drugs such as Lipitor, Pfizer’s anti-cholesterol medicine that is the biggest selling medication in history, big pharma is having to rethink its business model.

Most large pharmaceutical companies have adopted four principal strategies to diversify. First, expand the range of products in the research and development pipeline and the use of external as well as in-house scientists to discover them. Second, expand geographically, especially into emerging markets. Third, increase sales of products other than patented prescription medicines. Fourth, experiment with greater flexibility in pricing in different countries and with ways to ensure drugs provide value for money.

Read the rest of the article -- FinancialTimes.com

Visit us at www.advancedclinical.com

Saturday, May 15, 2010

Risk Management from Advanced Clinical

Risk is a huge problem in clinical trials, and Advanced Clinical is swift and professional about identifying, assessing, prioritizing, mitigating and tracking risks to proactively avoid those risks – before they become issues that cause the trial to delay the trial. Some risks, unmitigated, can cause 2 years of delay! At a direct and indirect slippage cost of $6MM - $15MM/day, that adds up!

Advanced Clinical:

o Assesses risks
o Prioritizes risks
o Reduces uncertainty
o Mitigates risks
o Manages/monitors risks
o Optimizes procedures to reverse risks

Advanced Clinical recognizes the four types of risk: operational, strategic, financial, and market, so no area is overlooked. Advanced Clinical also assesses the scale of the impact, and the likelihood of occurrence of the risk over the trial period.

We want success and advancement for your discovery's trial as much as you do, and managing and mitigating risks is one of our keys to success.

Does this sound like a great way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Tuesday, May 4, 2010

Women’s Cancer Awareness Week

With Mother's Day around the corner on May 9, it also marks the week for women's health and cancer awareness.

In spite of social leaps and bounds women have made in recent decades, there are still distinct differences between the bodies of men and women. There are many cancers that affect only women, or mostly women: breast cancer, fallopian tube cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. Birth control pills can put women at risk of breast tenderness, gall bladder disease, bloating, nausea, acne, and headaches. Women are more susceptible to mood disorders like depression and anxiety.



Women go through menopause. Here is a great article from Google about how to ease symptoms of menopause and what to expect.

It's not all that bad being a lady, though. Women typically have a larger deep limbic system than men, which allows them to be more in touch with feelings and better able to express those feelings, which promotes bonding and friendship with others. Women are also blessed with the gifts of childbirth and breastfeeding, which form immediate and permanent bonds with her child.

Medicine is making new strides everyday to advance discoveries to ease symptoms, cure disease, and better the human situation. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com